← Back to Search

HOBSCOTCH Program for Epilepsy

N/A
Waitlist Available
Led By Cam Escoffery, PhD, MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of epilepsy (self-reported by participant), with controlled or uncontrolled seizures
Be older than 18 years old
Must not have
No diagnosis of epilepsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, months 3, 6, 9, 12
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a home-based self-management program (HOBSCOTCH) can improve quality of life and perceived difficulties in cognitive abilities. The study will also test a new mobile application and extra booster sessions to improve long-term outcomes.

Who is the study for?
This trial is for individuals with epilepsy, who have memory complaints and stable medication regimens. They must be literate, have telephone and internet access, but cannot participate if they have dementia, severe mental disability (IQ less than 70), significant visual impairment, or lack a diagnosis of epilepsy.
What is being tested?
The study tests the HOBSCOTCH program—a home-based self-management strategy to improve quality of life and cognitive abilities in people with epilepsy. It includes a mobile app and optional booster sessions. Participants are split into two groups: one starts immediately; the other waits six months.
What are the potential side effects?
Since this trial involves a self-management program rather than medication, traditional side effects are not expected. However, participants may experience frustration or stress while learning new problem-solving strategies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have epilepsy with seizures that may or may not be under control.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have never been diagnosed with epilepsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, months 3, 6, 9, 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, months 3, 6, 9, 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Neuro Quality of Life (Neuro-QOL) Item Bank v2.0 - Cognitive Function Score
Change in Quality of Life in Epilepsy (QOLIE-31) Score
Secondary study objectives
Change in Adult Epilepsy Self-Management Measurement Instrument (AESMMI-65) Score
Change in Health Care Utilization
Change in Health Confidence Score (HCS)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HOBSCOTCH groupExperimental Treatment1 Intervention
Participants in this study arm will receive the HOBSCOTCH intervention immediately.
Group II: Wait-listed controlActive Control1 Intervention
Participants in this study arm will be wait-listed for 6 months and will then receive the HOBSCOTCH intervention.

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
892 Previous Clinical Trials
22,000,669 Total Patients Enrolled
7 Trials studying Epilepsy
835 Patients Enrolled for Epilepsy
Emory UniversityLead Sponsor
1,708 Previous Clinical Trials
2,607,391 Total Patients Enrolled
9 Trials studying Epilepsy
1,224 Patients Enrolled for Epilepsy
Cam Escoffery, PhD, MPHPrincipal Investigator - Emory University
Emory University
Katie Bullinger, MD, PhDPrincipal InvestigatorEmory University

Media Library

HOBSCOTCH Clinical Trial Eligibility Overview. Trial Name: NCT04639206 — N/A
Epilepsy Research Study Groups: HOBSCOTCH group, Wait-listed control
Epilepsy Clinical Trial 2023: HOBSCOTCH Highlights & Side Effects. Trial Name: NCT04639206 — N/A
HOBSCOTCH 2023 Treatment Timeline for Medical Study. Trial Name: NCT04639206 — N/A
~20 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top